Company Overview

SBI ALApharma Canada Inc. is a Toronto-based medical imaging company. We are currently expanding the clinical translation and applications of our proprietary handheld EagleTM imaging technology.

We aim to use our EagleTM fluorescence imaging device alongside the fluorescence contrast prodrug 5-Aminolevulinic Acid (5-ALA). We hope to improve the detection and resection of breast tumor cells intraoperatively - in real time - during index breast conserving surgery.

Established in August 2019, SBI ALApharma Canada Inc. is a wholly-owned subsidiary of Photonamic GmbH & Co. KG in Pinneberg, Germany (PHN).

Interested in becoming
a clinical partner?

We are currently recruiting new clinical sites in the USA and Canada.

Are you a surgeon who performs breast-conserving lumpectomies at your institution?

Do you wish to learn more about this clinical trial? Please fill in your details here. Our clinical team will reach out to you about becoming a site with this Phase III clinical trial.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.